The collaboration of leading freight forwarders continues to cement the credibility of the HOPE consortium as the main platform for sourcing logistical solutions for distributing Covid-19 vaccines globally.
Spearheaded by the Department of Health – Abu Dhabi, the HOPE Consortium comprises some of the UAE’s and global leading supply chain solution players, including Abu Dhabi Ports, as lead partner, Etihad Cargo and Rafed, as well as Switzerland’s SkyCell.
H.E Dr. Jamal Mohammed Al Kaabi, Undersecretary of Department of Health – Abu Dhabi, said: “Increasing our partners to 16 enables the HOPE consortium to continue to expand its reach and services to be a major player in the global logistical space for distributing billions of doses of Covid-19 vaccines, despite the great logistical challenge of transporting doses safely while maintaining their integrity. Partnering with more world-class freight forwarders enables the consortium to address the different needs of countries, NGOs, and pharma needs for most of the world. The consortium is part of the UAE’s efforts to provide solutions that support the global fight against Covid-19.”
Bolloré Logistics is a major international supply chain operator and ranks among the world’s top 10 transport and logistics groups with an integrated network of 600 offices in 109 countries with 36,500 employees. Through the reliable management of the entire supply chain, the company has developed a high level of resilience enabling it to control risks by securing transport plans through alternative options and to lead a continuous improvement policy over the long term while acting as an ethical and responsible player.
Philippe Lortal, CEO, Middle East & South Asia, Bolloré Logistics, said: “Bolloré Logistics is gearing up with the various stakeholders for the global distribution of COVID-19 vaccines and is committed to providing distribution solutions connecting vaccine production and distribution centres to destination medical centres. The company has created a special task force that will design logistics solutions ensuring the seamless distribution of the vaccines.”
